Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Haddad

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
The Journal of Clinical Endocrinology and Metabolism|April 8, 2010
Vandetanib (100 mg) in patients with locally advanced or metastatic hereditary medullary thyroid cancerBruce G Robinson, Luis Paz-Ares, Annetta Krebs, et al.
The Oncologist|April 26, 2013
Organ preservation for adenoid cystic carcinoma of the larynxKrzysztof J Misiukiewicz, Nadia Camille, Roy Tishler, et al.
Oral Oncology|December 7, 2007
HPV16 transmission between a couple with HPV-related head and neck cancerRobert Haddad, Christopher Crum, Zigui Chen, et al.
Cancer Treatment Reviews|April 29, 2018
Management of treatment-related toxicities in advanced medullary thyroid cancerMarcia S Brose, Keith C Bible, Laura Q M Chow, et al.
Oral Oncology|June 4, 2013
A randomized phase II study of docetaxel with or without vandetanib in recurrent or metastatic squamous cell carcinoma of head and neck (SCCHN)Sewanti Limaye, Sarah Riley, Sihai Zhao, et al.
Future Oncology (London, England)|April 18, 2025
STELLAR-305: phase II/III study of zanzalintinib plus pembrolizumab versus pembrolizumab alone in patients with HNSCCNabil F Saba, Kevin Harrington, Lisa Licitra, et al.
Anatomical Sciences Education|November 11, 2018
Active Learning of the Floor of Mouth Anatomy with UltrasoundFloyd E Bell, Francis H Neuffer, T Robert Haddad, et al.
Archives of Otolaryngology--Head & Neck Surgery|June 21, 2006
Rate of pathologic complete responses to docetaxel, cisplatin, and fluorouracil induction chemotherapy in patients with squamous cell carcinoma of the head and neckRobert Haddad, Roy Tishler, Lori Wirth, et al.
Cancer Treatment Reviews|November 2, 2013
Targeted therapies for squamous cell carcinoma of the head and neck: current knowledge and future directionsSandra Schmitz, Kie Kian Ang, Jan Vermorken, et al.
Cancer|June 22, 2011
Patient-reported receipt of and interest in smoking-cessation interventions after a diagnosis of cancerMary E Cooley, Karen M Emmons, Robert Haddad, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
The Journal of Clinical Endocrinology and Metabolism|April 8, 2010
Vandetanib (100 mg) in patients with locally advanced or metastatic hereditary medullary thyroid cancerBruce G Robinson, Luis Paz-Ares, Annetta Krebs, et al.
The Oncologist|April 26, 2013
Organ preservation for adenoid cystic carcinoma of the larynxKrzysztof J Misiukiewicz, Nadia Camille, Roy Tishler, et al.
Oral Oncology|December 7, 2007
HPV16 transmission between a couple with HPV-related head and neck cancerRobert Haddad, Christopher Crum, Zigui Chen, et al.
Cancer Treatment Reviews|April 29, 2018
Management of treatment-related toxicities in advanced medullary thyroid cancerMarcia S Brose, Keith C Bible, Laura Q M Chow, et al.
Oral Oncology|June 4, 2013
A randomized phase II study of docetaxel with or without vandetanib in recurrent or metastatic squamous cell carcinoma of head and neck (SCCHN)Sewanti Limaye, Sarah Riley, Sihai Zhao, et al.
Future Oncology (London, England)|April 18, 2025
STELLAR-305: phase II/III study of zanzalintinib plus pembrolizumab versus pembrolizumab alone in patients with HNSCCNabil F Saba, Kevin Harrington, Lisa Licitra, et al.
Anatomical Sciences Education|November 11, 2018
Active Learning of the Floor of Mouth Anatomy with UltrasoundFloyd E Bell, Francis H Neuffer, T Robert Haddad, et al.
Archives of Otolaryngology--Head & Neck Surgery|June 21, 2006
Rate of pathologic complete responses to docetaxel, cisplatin, and fluorouracil induction chemotherapy in patients with squamous cell carcinoma of the head and neckRobert Haddad, Roy Tishler, Lori Wirth, et al.
Cancer Treatment Reviews|November 2, 2013
Targeted therapies for squamous cell carcinoma of the head and neck: current knowledge and future directionsSandra Schmitz, Kie Kian Ang, Jan Vermorken, et al.
Cancer|June 22, 2011
Patient-reported receipt of and interest in smoking-cessation interventions after a diagnosis of cancerMary E Cooley, Karen M Emmons, Robert Haddad, et al.
Pageof 8